Soleno Therapeutics (SLNO)

• Market cap: $2.79B
• 1 day: 5.07%
• 5 days: -0.61%
• 1 month: 8.95%
• 3 months: -3.02%
• 6 months: -35.16%
• Year to date: 13.76%
• 1 year: 12.36%
• 5 years: 86.38%
• 10 years: -59.92%
• Sector: Healthcare
• Industry: Biotechnology

About: Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

Employees: 152